For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Noriaki Ishida, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

The Japan Research Foundation for Clinical Pharmacology, A Daiichi Sankyo Foundation, has awarded 5th Annual Clinical Pharmacology Research Award

Tokyo, Japan (June 29, 2012) – Daiichi Sankyo Company, Limited announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology (headquarters: Tokyo, Director General: Kiyoshi Morita) has awarded its 5th “Japan Research Foundation for Clinical Pharmacology Research Award” to six young researchers this year.

 

Awardees are selected from research papers submitted from projects funded with subsidies from the foundation. Innovative research projects with expectations for future development are eligible for the award.

 

The Foundation hopes that the award will motivate young researchers in clinical pharmacology involved in establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentations of the research themes will be held on November 9, 2012.

 

The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and it has worked on a variety of projects relating to clinical pharmacology, including promotion of research, overseas studies for Japanese researchers and Asian international collaborations.

 

 

5th Japan Research Foundation for Clinical Pharmacology Research Awardees 

 

Awardees	Organization	Research theme
Naoki Inui	Department of Clinical Pharmacology and Therapeutics                                   Hamamatsu University School of Medicine	The chronological assessment of cytochrome P450 activity using cocktail assay
Hiroyuki Uchida	Department of Neuropsychiatry                     Keio University School of Medicine	Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study
Hiroyuki Kusuhara	Laboratory of Molecular Pharmacokinetics Graduate School of Pharmaceutical Sciences   The University of Tokyo	Investigation of the importance of H+/organic cation exchanger, MATE in renal drug elimination of drugs −A pharmacokinetic interaction study using a MATE inhibitor pyrimethamine−
Yoshiyuki Kojima	Department of Nephro-Urology              Graduate School of Medical Sciences        Nagoya City University                         (Present)　 Department of Urology     Fukushima Medical University School of Medicine	Pharmacogenomics-based personalized medicine in benign prostatic hyperplasia
Hideki Hayashi	Department of Clinical Pharmacology & Genetics                                                 School of Pharmaceutical Science            University of Shizuoka	Genetic polymorphism for predicting the efficacy of methotrexate in rheumatoid arthritis
Yuki Asano-Mori	Department of Hematology                 Federation of National Public Service     Personnel Mutual Aid Associations       Toranomon Hospital	Clinical and pharmacokinetic evaluation of prophylactic second-generation triazoles against invasive fungal infections in hematopoietic stem cell transplant recipients